20-Hydroxyecdysone decreases weight and hyperglycemia in a diet-induced obesity mice model

American Journal of Physiology - Endocrinology and Metabolism

Volumn 296, Issue 3, 2009, Pages

  Kizelsztein, Pablo ^a   Govorko, Dmitry ^a   Komarnytsky, Slavko ^a   Evans, Alysa ^a   Wang, Zhong ^b   Cefalu, William T ^b   Raskin, Ilya ^a  

^a RUTGERS UNIVERSITY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Adiponectin; Gluconeogenic enzymes; Obesity and diabetes

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENYLATE KINASE; ADIPONECTIN; ECDYSTERONE; GLUCOSE 6 PHOSPHATASE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN KINASE B BETA; ADIPONECTIN, MOUSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; WEIGHT REDUCTION; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CELL CULTURE; CHEMISTRY; FAT INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; DIETARY FATS; ECDYSTERONE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; OBESITY; RATS; STAT1 TRANSCRIPTION FACTOR;

EID: 64749102394     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90772.2008     Document Type: Article

References (40)

1. Agati JM, Yeagley D, Quinn PG. Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP-induced phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 273: 18751-18759, 1998. (Pubitemid 28366259)
2. Barnea M, Shamay A, Stark AH, Madar Z. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 14: 2145-2153, 2006. (Pubitemid 46121969)
3. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953, 2001. (Pubitemid 32756433)
4. Brommage R. Validation and calibration of DEXA body composition in mice. Am J Physiol Endocrinol Metab 285: E454-E459, 2003. (Pubitemid 37010821)
5. Bullen JW Jr, Bluher S, Kelesidis T, Mantzoros CS. Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 292: E1079-E1086, 2007. (Pubitemid 46536507)
6. Chen Q, Xia Y, Qiu Z. Effect of ecdysterone on glucose metabolism in vitro. Life Sci 78: 1108-1113, 2006. (Pubitemid 43143469)
7. Chiang HC, Wang JJ, Wu RT. Immunomodulating effects of the hydrolysis products of formosanin C and beta-ecdysone from Paris formosana Hayata. Anticancer Res 12: 1475-1478, 1992.
8. Colombani J, Bianchini L, Layalle S, Pondeville E, Dauphin-Villemant C, Antoniewski C, Carre C, Noselli S, Leopold P. Antagonistic actions of ecdysone and insulins determine final size in Drosophila. Science 310: 667-670, 2005. (Pubitemid 41528157)
9. Dinan L. Phytoecdysteroids: biological aspects. Phytochemistry 57: 325-339, 2001. (Pubitemid 32448444)
10. Dzucharova MC, Sachidov AD, Kasimov B, Syrov VN, Takanaev AA, Saatov Z. Pharmacokinetics of ecdysterone. Chemico-Pharmacol J 10: 1163-1167, 1987.
11. El Hilaly J, Lyoussi B. Hypoglycaemic effect of the lyophilised aqueous extract of Ajuga iva in normal and streptozotocin diabetic rats. J Ethnopharmacol 80: 109-113, 2002. (Pubitemid 34462196)
12. Govorko D, Logendra S, Wang Y, Esposito D, Komarnytsky S, Ribnicky D, Poulev A, Wang Z, Cefalu WT, Raskin I. Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line. Am J Physiol Endocrinol Metab 293: E1503-E1510, 2007. (Pubitemid 350255099)
13. Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66: 581-611, 1997. (Pubitemid 27274668)
14. Harmatha J, Vokac K, Kmonickova E, Zidek Z. Lack of interference of common phytoecdysteroids with production of nitric oxide by immune-activated mammalian macrophages. Steroids 73: 466-471, 2008.
15. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000. (Pubitemid 30353893)
16. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703, 1996. (Pubitemid 26145805)
17. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P, Takemori H, Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437: 1109-1111, 2005. (Pubitemid 41509342)
18. Koolman J. Ecdysone: from Chemistry to Mode of Action. New York: Stuttgart, 1989.
19. Korkach Iu P, Kotsiuruba AV, Prysiazhna OD, Mohyl'nyts'ka LD, Sahach VF. [NO-dependent mechanisms of ecdysterone protective action on the heart and vessels in streptozotocin-induced diabetes mellitus in rats]. Fiziol Zh 53: 3-8, 2007.
20. Korkach Iu P, Rudyk OV, Kotsiuruba AV, Prysiazhna OD, Sahach VF. [The role of nitric oxide and superoxide synthesis in protective mechanism of ecdysterone in the heart mitochondria of rats with streptozotocin-induced diabetes]. Fiziol Zh 53: 22-28, 2007.
21. Kurmukov AG, Ermishina OA. [The effect of ecdysterone on experimental arrhythmias and changes in the hemodynamics and myocardial contractility induced by coronary artery occlusion]. Farmakol Toksikol 54: 27-29, 1991.
22. Kutepova TA, Syrov VN, Khushbatkova ZA, Saatov Z. Hypoglycemic activity of the total ecdysteroid extract from Ajuga Turkestanica. Pharmaceut Chem J 35: 24-25, 2001.
23. Lazar MA. How obesity causes diabetes: not a tall tale. Science 307: 373-375, 2005.
24. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8: 731-737, 2002.
25. Matsuda H, Kawaba T, Yamamoto Y. [Pharmacological studies of insect metamorphotic steroids]. Nippon Yakurigaku Zasshi 66: 551-563, 1970.
26. Mironova VN, Kholodova IuD, Skachkova TF, Bondar' OP, Datsenko ZM. [Hypocholesterolemic effect of phytoecdysones during experimental hypercholesterolemia in rats]. Vopr Med Khim 28: 101-105, 1982.
27. Nagy TR, Clair AL. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes Res 8: 392-398, 2000.
28. Pirola L, Johnston AM, Van Obberghen E. Modulation of insulin action. Diabetologia 47: 170-184, 2004. (Pubitemid 38315353)
29. Schmelz EA, Grebenok RJ, Ohnmeiss TE, Bowers WS. Interactions between Spinacia oleracea and Bradysia impatiens: a role for phytoecdysteroids. Arch Insect Biochem Physiol 51: 204-221, 2002.
30. Syrov V, Sharapova R, Kurmukov A. Effect of Ecdysterone on the hematopoietic activity on the laboratory animals with experimental anemia. Issues Obstetr Gynecol 1: 62-63, 1976.
31. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248, 1994.
32. Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277: 34933-34940, 2002.
33. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935, 2001. (Pubitemid 32472900)
34. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, Weber P. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136: 2512-2518, 2006. (Pubitemid 44521606)
35. Wu C, Okar DA, Kang J, Lange AJ. Reduction of hepatic glucose production as a therapeutic target in the treatment of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 5: 51-59, 2005. (Pubitemid 40394303)
36. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002. (Pubitemid 35373562)
37. Yang J, Maika S, Craddock L, King JA, Liu ZM. Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice. Biochem Biophys Res Commun 370: 248-253, 2008.
38. Yoshida T, Otaka T, Uchiyama M, Ogawa S. Effect of ecdysterone on hyperglycemia in experimental animals. Biochem Pharmacol 20: 3263-3268, 1971.
39. Yuan L, Ziegler R, Hamann A. Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes. Chin Med J (Engl) 115: 1843-1848, 2002. (Pubitemid 36105064)
40. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 29: 6S9-6S18, 2003. (Pubitemid 37187086)